Physician profile
Ralph P Page
NPI 1770569527
$2,253.98
in general payments reported to CMS, 2019-2025
26 companies · $1,012 in 2025
The $1,012 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.26 · 2020: $80.18 · 2021: $78.35 · 2022: $135 · 2023: $166 · 2024: $698 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,875.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $424.18 | 2025 | Carvykti, Rybrevant |
| Astrazeneca Pharmaceuticals LP | $316.36 | 2024-2025 | Airsupra, Breztri |
| Dendreon Pharmaceuticals LLC | $149.86 | 2025 | Provenge |
| Abbvie INC. | $144.48 | 2021-2024 | |
| Emd Serono, INC. | $124.46 | 2024 | |
| Kite Pharma, INC. | $124.46 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $124.46 | 2025 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $124.46 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.46 | 2025 | |
| Nestle Healthcare Nutrition INC. | $97.39 | 2021-2023 | |
| Exact Sciences Corporation | $70.11 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $63.15 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $53.88 | 2024 | Voquezna |
| Allergan, INC. | $46.01 | 2019-2020 | |
| Ucb, INC. | $39.78 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.96 | 2019-2024 | Jardiance, Synjardy |
| Amgen INC. | $34.95 | 2024 | Otezla, Repatha |
| Almatica Pharma LLC | $21.12 | 2022 | |
| Sunovion Pharmaceuticals INC. | $18.80 | 2019 | |
| Biodelivery Sciences International, INC. | $18.09 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.56 | 2021 | |
| Lilly USA, LLC | $17.50 | 2023 | Jardiance |
| Horizon Therapeutics Plc | $15.63 | 2020 | |
| Abbott Laboratories | $15.43 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.41 | 2024 | Xifaxan, Trulance |
| Eisai INC. | $14.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Page listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.